1,248 Shares in Balchem Co. (NASDAQ:BCPC) Acquired by Private Advisor Group LLC

Private Advisor Group LLC acquired a new position in shares of Balchem Co. (NASDAQ:BCPC) during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund acquired 1,248 shares of the basic materials company’s stock, valued at approximately $220,000.

Other large investors also recently added to or reduced their stakes in the company. Vanguard Group Inc. grew its holdings in shares of Balchem by 3.8% during the first quarter. Vanguard Group Inc. now owns 3,935,935 shares of the basic materials company’s stock valued at $609,873,000 after buying an additional 144,423 shares in the last quarter. Price T Rowe Associates Inc. MD increased its holdings in shares of Balchem by 32.2% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 193,146 shares of the basic materials company’s stock valued at $29,929,000 after purchasing an additional 47,036 shares during the period. Conestoga Capital Advisors LLC lifted its position in shares of Balchem by 2.7% in the second quarter. Conestoga Capital Advisors LLC now owns 1,155,209 shares of the basic materials company’s stock worth $177,844,000 after purchasing an additional 29,825 shares in the last quarter. Watts Gwilliam & Co. LLC acquired a new stake in shares of Balchem during the third quarter worth approximately $3,639,000. Finally, William Blair Investment Management LLC boosted its holdings in shares of Balchem by 8.4% during the second quarter. William Blair Investment Management LLC now owns 233,831 shares of the basic materials company’s stock worth $35,998,000 after purchasing an additional 18,104 shares during the period. 87.91% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of equities research analysts have issued reports on the stock. StockNews.com upgraded shares of Balchem from a “hold” rating to a “buy” rating in a research report on Monday, October 28th. HC Wainwright upped their price target on shares of Balchem from $185.00 to $190.00 and gave the stock a “buy” rating in a research note on Monday.

Balchem Stock Down 3.7 %

BCPC opened at $176.63 on Friday. The company has a market capitalization of $5.74 billion, a PE ratio of 47.48, a price-to-earnings-growth ratio of 5.28 and a beta of 0.65. The business has a 50-day moving average of $172.07 and a 200-day moving average of $163.86. Balchem Co. has a fifty-two week low of $116.84 and a fifty-two week high of $186.03. The company has a debt-to-equity ratio of 0.21, a current ratio of 2.98 and a quick ratio of 1.90.

Balchem Profile

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.